FDA Inspection 723863 — Cambrex Profarmaco Milano Srl
The FDA completed an inspection of Cambrex Profarmaco Milano Srl on March 25, 2011 in Paullo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paullo (Italy)